Vimarsana
Biggest News Aggregation in the World

Rsys Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rsys Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rsys Group Today - Breaking & Trending Today

Yayasan Sabah allocates RM67.4mil for state youths seeking further studies, says Hajiji Noor - Vimarsana News

Yayasan Sabah allocates RM67.4mil for state youths seeking further studies, says Hajiji Noor

KOTA KINABALU: Yayasan Sabah (YS) Group is allocating RM67.4mil in 2024, an increase from RM53.8mil last year, to allow more Sabah youths to further their tertiary studies overseas or in the country, says Chief Minister Datuk Seri Hajiji Noor.

YS Biopharma Announces Appointment of New Directors - Vimarsana News

YS Biopharma Announces Appointment of New Directors

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company", and together with its subsidiaries, "YS Group"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the appointment of six new members to its Board of Directors (the "Board"), effective February 13, 2024. The six new directors are: Dr. Yuntao Cui; Dr. Jin Wang; Mr. Henry

Source: yahoo.com
YS Biopharma Announces US$40 Million Private Placement Financing - Vimarsana News

YS Biopharma Announces US$40 Million Private Placement Financing

GAITHERSBURG, Md., Feb. 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. along with its subsidiaries , a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and...

Shareholders of YS Biopharma Announce an Extraordinary General Meeting - Vimarsana News

Shareholders of YS Biopharma Announce an Extraordinary General Meeting

/PRNewswire/ -- Shareholders of YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma"), a global biopharmaceutical company dedicated to discovering, developing,...

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 - Vimarsana News

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical...